share_log

Avenue Therapeutics Q4 EPS $(0.98) Misses $(0.10) Estimate

Avenue Therapeutics Q4 EPS $(0.98) Misses $(0.10) Estimate

Avenue Therapeutics第四季度每股收益美元(0.98美元)未达到预期(0.10美元)
Moomoo 24/7 ·  03/18 16:15

Avenue Therapeutics (NASDAQ:ATXI) reported quarterly losses of $(0.98) per share which missed the analyst consensus estimate of $(0.10) by 880 percent. This is a 20.33 percent increase over losses of $(1.23) per share from the same period last year.

Avenue Therapeutics(纳斯达克股票代码:ATXI)公布的季度亏损为每股0.98美元,比分析师普遍预期的0.10美元(0.10美元)低880%。这比去年同期每股亏损1.23美元(1.23美元)增长了20.33%。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发